These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
680 related articles for article (PubMed ID: 30745827)
1. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis. Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827 [TBL] [Abstract][Full Text] [Related]
2. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101 [TBL] [Abstract][Full Text] [Related]
4. miR-595 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting NF-κB signalling pathway. Wang H; Jiang F; Liu W; Tian W Pathol Res Pract; 2020 Apr; 216(4):152899. PubMed ID: 32107085 [TBL] [Abstract][Full Text] [Related]
5. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival. Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373 [TBL] [Abstract][Full Text] [Related]
6. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641 [TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma. Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells. Huan L; Bao C; Chen D; Li Y; Lian J; Ding J; Huang S; Liang L; He X Cancer Sci; 2016 Mar; 107(3):258-66. PubMed ID: 26708147 [TBL] [Abstract][Full Text] [Related]
10. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α. Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4. Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037 [TBL] [Abstract][Full Text] [Related]
12. Effects of miR-155 on proliferation and apoptosis by regulating FoxO3a/BIM in liver cancer cell line HCCLM3. Liao WW; Zhang C; Liu FR; Wang WJ Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1277-1285. PubMed ID: 29565484 [TBL] [Abstract][Full Text] [Related]
13. Roles of microRNA-330 and Its Target Gene ING4 in the Development of Aggressive Phenotype in Hepatocellular Carcinoma Cells. Hu X; Feng Y; Sun L; Qu L; Sun C Dig Dis Sci; 2017 Mar; 62(3):715-722. PubMed ID: 28050784 [TBL] [Abstract][Full Text] [Related]
14. MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1. Dong ZB; Wu HM; He YC; Huang ZT; Weng YH; Li H; Liang C; Yu WM; Chen W Cell Death Dis; 2022 Jan; 13(1):35. PubMed ID: 35013144 [TBL] [Abstract][Full Text] [Related]
15. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation. Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501 [TBL] [Abstract][Full Text] [Related]
16. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells. Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874 [TBL] [Abstract][Full Text] [Related]
17. Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis. Guo K; Kang NX; Li Y; Sun L; Gan L; Cui FJ; Gao MD; Liu KY BMC Cancer; 2009 Mar; 9():100. PubMed ID: 19331697 [TBL] [Abstract][Full Text] [Related]
18. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
19. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway. Zhao L; Zhang Y Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008 [TBL] [Abstract][Full Text] [Related]
20. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]